InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Atlas Venture Fund XI, L.P.. Officer active across 6 companies, notably Day One Biopharmaceuticals, Inc.. In total, 18 disclosures have been recorded. Split: 1 buy · 8 sells. Total volume traded: €11.7m. Activity tracked since 13 July 2021. The latest transaction was filed on 1 November 2024 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Atlas Venture Fund XI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
2,886,293 sharesCommon StockSEC:0000950170-25-017030:0
515,688 shares0Common StockSEC:0001415889-24-026125:0
136,312 shares@ US$23.5929.8% of flowCommon StockSEC:0001415889-24-005777:0
149,337 shares@ US$22.4431.0% of flowCommon StockSEC:0001415889-24-005124:0
175,793 shares@ US$23.8839.2% of flowCommon StockSEC:0001415889-24-004467:0
733 shares@ US$0.6411.7% of flowCommon StockSEC:0001209191-24-003031:0
1,566 shares@ US$0.8733.4% of flowCommon StockSEC:0001209191-24-001655:0
569 shares@ US$0.8712.1% of flowCommon StockSEC:0001209191-24-001655:1
1,540 shares@ US$0.8331.3% of flowCommon StockSEC:0001209191-24-001655:2
560 shares@ US$0.8311.4% of flowCommon StockSEC:0001209191-24-001655:3
600,854 shares0Common StockSEC:0001209191-22-061242:0
600,854 shares0Common StockSEC:0001209191-22-050928:0
6,472,374 sharesCommon StockSEC:0001209191-22-050535:0
125,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-21-069644:0
Canonical exit: 28 Jun 2021 (T+90)
801,138 shares0Common StockSEC:0001209191-21-067018:0
1,372,998 sharesCommon StockSEC:0001104659-21-130026:0
814,013 shares0Common StockSEC:0001209191-21-046784:0
7,761,380 sharesCommon StockSEC:0001209191-21-037402:0
18 of 18 declarations
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. is a declarant with 18 filings in total, linked to Xilio Therapeutics, Inc., Dyne Therapeutics, Inc., Day One Biopharmaceuticals, Inc., Third Harmonic Bio, Inc., Sionna Therapeutics, Inc. and Ikena Oncology, Inc. Over the sampled recent filings, from 2021-06-02 to 2025-02-10, the amounts shown are EUR 1705960 in purchases and EUR 9986276 in sales, with Cession as the modal transaction nature.
